Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour. Local targets link to admitted publications; unresolved targets remain external evidence.
Global disparities in wilms tumor
10.1016/j.jss.2019.10.044 · 2020 · External reference
10.1111/j.1365-3016.2010.01133.x
10.1111/j.1365-3016.2010.01133.x · External reference
International variations in the incidence of childhood renal tumours
10.1038/bjc.1990.432 · 1990 · External reference
Wilms Tumor
2020 · External reference
Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment
10.21037/tau.2020.03.27 · 2020 · External reference
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
10.1136/jmg.2006.041723 · 2006 · External reference
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
10.1002/pbc.21267 · 2008 · External reference
Update on Wilms tumor
10.1016/j.jpedsurg.2018.09.005 · 2019 · External reference
Relation between cellular immunity to nephroblastoma and the phase of the disease
10.1111/j.1651-2227.1972.tb15972.x · 1972 · External reference
10.1203/00006450-199707000-00019
10.1203/00006450-199707000-00019 · External reference
10.1158/1078-0432.ccr-05-1824
10.1158/1078-0432.ccr-05-1824 · External reference
10.1016/j.jpurol.2019.03.011
10.1016/j.jpurol.2019.03.011 · External reference
10.1177/1010428320975976
10.1177/1010428320975976 · External reference
10.1016/j.tranon.2014.05.008
10.1016/j.tranon.2014.05.008 · External reference
Unresolved reference
External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
10.1038/ng.3940
10.1038/ng.3940 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
10.1371/journal.pone.0001195
10.1371/journal.pone.0001195 · External reference
10.1016/j.neo.2019.04.003
10.1016/j.neo.2019.04.003 · External reference
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
2017 · External reference
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
10.1186/gb-2014-15-3-r47 · 2014 · External reference
10.3389/fmed.2020.615599
10.3389/fmed.2020.615599 · External reference
CD14(+) monocytes and CD163(+) macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C
2020 · External reference
10.1016/j.celrep.2021.109105
10.1016/j.celrep.2021.109105 · External reference
Monocyte differentiation into destructive macrophages on in vitro administration of gingival crevicular fluid from periodontitis patients
10.3390/jpm11060555 · 2021 · External reference
Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations
10.1016/j.exger.2021.111317 · 2021 · External reference
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
10.1186/s12943-019-0941-2 · 2019 · External reference
10.1007/s10753-019-01030-0
10.1007/s10753-019-01030-0 · External reference
10.1038/nmeth.2089
10.1038/nmeth.2089 · External reference
Recent advances in the management of Wilms' tumor
10.12688/f1000research.10760.1 · 2017 · External reference
10.1016/j.cell.2017.10.044
10.1016/j.cell.2017.10.044 · External reference
Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis
10.1158/1078-0432.ccr-13-3173 · 2015 · External reference
10.1002/bjs.10871
10.1002/bjs.10871 · External reference
10.1038/nm.3909
10.1038/nm.3909 · External reference
10.1016/j.cell.2010.03.014
10.1016/j.cell.2010.03.014 · External reference
10.1016/j.it.2011.12.001
10.1016/j.it.2011.12.001 · External reference
The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
10.1002/cam4.2433 · 2019 · External reference
Correlation of tumor-associated macrophages and clinicopathological factors in Wilms tumor
10.1186/2045-824x-5-5 · 2013 · External reference
Relationship of tumour-associated macrophages with poor prognosis in Wilms' tumour
10.1016/j.jpurol.2020.03.016 · 2020 · External reference
Wilms' tumor primary cells display potent immunoregulatory properties on NK cells and macrophages
10.3390/cancers13020224 · 2021 · External reference
Prognostic factors and nomograms to predict overall and cancer-specific survival for children with wilms' tumor
10.1155/2019/1092769 · 2019 · External reference
10.3389/fphys.2014.00075
10.3389/fphys.2014.00075 · External reference
Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances
10.3390/s18103249 · 2018 · External reference
Promotion of Wilms' tumor cells migration and invasion by mono-2-ethyhexyl phthalate (MEHP) via activation of NF-kappaB signals
10.1016/j.cbi.2017.04.004 · 2017 · External reference
Curcumin suppresses wilms' tumor metastasis by inhibiting RECK methylation
10.1016/j.biopha.2018.12.111 · 2019 · External reference
10.1080/10408363.2020.1770685
10.1080/10408363.2020.1770685 · External reference
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis
10.23736/s0392-9590.17.03848-2 · 2018 · External reference
Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
10.1097/md.0000000000018571 · 2020 · External reference
Energy metabolism in neuroblastoma and Wilms tumor
2015 · External reference
10.1158/0008-5472.can-12-0006
10.1158/0008-5472.can-12-0006 · External reference
Basis of PD1/PD-L1 therapies
10.3390/jcm8122168 · 2019 · External reference
Biomarkers for predicting efficacies of anti-PD1 antibodies
10.3389/fmed.2019.00174 · 2019 · External reference
10.3389/fcell.2020.00672
10.3389/fcell.2020.00672 · External reference
